Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis;Les immunoglobulines intraveineuses dans les polymyosites et dermatomyosites

Annales de Medecine Interne

Volumn 151, Issue SUPPL. 1, 2000, Pages

  Cherin, Patrick ^a  

^a Service de Medecine Interne   (France)

Author keywords

Dermatomyositis; Immunoglobulins; Polymyositis

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; IMMUNOGLOBULIN;

CLINICAL TRIAL; DERMATOMYOSITIS; HUMAN; POLYMYOSITIS; REVIEW;

ADRENAL CORTEX HORMONES; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CAPILLARIES; DERMATOMYOSITIS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; MUSCLE FIBERS; MUSCLE, SKELETAL; POLYMYOSITIS; RECURRENCE;

EID: 0343526764     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. BOHAN A, PETER JB. Polymyositis and dermatomyositis. N Engl J Med, 1975; 292: 344-7 and 403-7.
2. PLOTZ PH, DALAKAS M, LEFF RL, LOVE LA, MILLER FW, CRONIN ME: Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med, 1989; 111: 143-57.
3. CHERIN P, CHOSIDOW O, HERSON S. Polymyosites et dermatomyosites. Actualités. Ann Dermatol Venereol, 1995; 122: 447-54.
4. DALAKAS MC. Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med, 1991; 325: 1487-98.
5. CHERIN P. Recognition and management of myositis. Drugs, 1997; 54: 39-49.
6. CHERIN P, HERSON S, CREVON MC, HAUW JJ, CERVERA P, GALANAUD P et al. Mechanisms of lysis by activated cytotoxic cells expressing perform and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis. J Rheumatol, 1996; 23: 1135-42.
7. CHERIN P, HERSON S, GODEAU P. Treatment of polymyositis and dermatomyositis. Eur J Intern Med, 1992; 3: 189-96.
8. CHERIN P, HERSON S, COUTELLIER A, BLETRY O, PIETTE JC. Failure of total body irradiation in polymyositis: report of three cases. Br J Rheumatol, 1992; XXXI: 282-3.
9. CHERIN P, HERSON S: Indications of Intravenous gammaglobulin therapy in inflammatory myopathies. J Neurol Neurosurg Psychiatry, 1994; 57 (S): 50-4.
10. CHERIN P, POURRAT J, BUSSEL A, AUPERIN I, HERSON S. Plasma exchange in polymyositis and dermatomyositis: analysis of 57 cases. Clin Exp Rheum, 1995; 13: 270-1.
11. BERKMAN SA, LEE ML, GALE RP: Clinical uses of intravenous immunoglobulins. Ann Intern Med, 1990; 112: 278-92.
12. CHERIN P, HERSON S, WECHSLER B, PIETTE JC, BLETRY O, ZIZA JM et al. Intravenous immunoglobulin for polymyositis and dermatomyositis. Lancet, 1990; 336: 116.
13. CHERIN P, HERSON S, WECHSLER B, PIETTE JC, BLETRY O, COUTELLIER A et al. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patients. Am J Med, 1991; 91: 162-8.
14. JANN S, BERETTA S, MOGGIO M, ADOBBATI L, PELLEGRINI G. High-dose intravenous human immunoglobulin in polymyositis resistant to treatment. J Neurol Neurosurg Psychiatry, 1992; 55: 60-2.
15. CHERIN P, HERSON S, WECHSLER B, BLETRY O, PIETTE JC, GODEAU P. Autoimmune diseases, IgA deficiency and intravenous immunoglobulin treatment. Am J Med, 1992; 93: 114-5.
16. DALAKAS MC, ILLA I, DAMBROSIA JM, SOUEIDAN SA, STEIN DP, OTERO C et al. A controlled trial of high dose intravenous immune globulin, infusions as treatment for dermatomyositis. N Engl J Med, 1993; 329: 1993-2000.
17. QI M, SCHIFFERLI JA. Inhibition of complement activation by intravenous immunoglobulins. Arthritis Rheum, 1995; 38: 146.
18. BASTA M, DALAKAS MC. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clinical Invest, 1994; 94: 1729-35.
19. CHERIN P, PIETTE JC, WECHSLER B, BLETRY O, ZIZA JM, LARAKI R et al. Intravenous gammaglobulin as first line therapy in polymyositis and dermatomyositis: a report of 11 cases. J Rheumatol, 1994; 21: 1092-7.
20. HERSON S, CHERIN P, COUTELLIER A. The association of plasma exchange synchronized with intravenous gamma globulin in severe intractable polymyositis. J Rheumatol, 1992; 19: 828-9.